期刊文献+

Tyk2促进前列腺癌细胞系雄激素受体特异位点Tyr-267磷酸化 被引量:1

Tyrosine kinase 2 facilitates site-specific tyrosine phosphorylation of androgen receptor for Tyr-267 in prostate cancer cell lines
下载PDF
导出
摘要 目的探讨JAK激酶家族成员Tyk2在雄激素受体(AR)磷酸化和前列腺癌细胞增殖中的作用。方法以LNCaP及LAPC-4细胞系为研究对象,在无雄激素条件下,用表皮生长因子(EGF)刺激,给予AIM-100/Baricitinib(INCB 028050)处理,免疫沉淀法和Western blot法检测AR磷酸化;将Tyk2 siRNA转染LNCaP及LAPC-4细胞系,用Western blot法检测沉默Tyk2对AR磷酸化的影响;用CCK-8试剂盒检测前列腺癌细胞增殖。结果 EGF诱导AR Tyr-267特异位点磷酸化并促进前列腺癌细胞增殖(P<0.05);AIM-100抑制Ack1和Tyk2介导的LNCaP/LAPC-4细胞增殖(P<0.05)和AR Tyr-267位点磷酸化;INCB抑制Tyk2磷酸化、AR Tyr-267位点磷酸化及LNCaP/LAPC-4细胞增殖(P<0.05)。结论 Tyk2是EGF诱导AR Tyr-267特异位点磷酸化和前列腺癌细胞增殖的关键激酶,在前列腺癌发病过程中可能扮演重要角色。 Objective To investigate the effect of the JAK family member Tyk2 on androgen receptor( AR) phosphorylation and the proliferation of prostate cancer cells. Methods LNCa P and LAPC-4 cell lines as subjects were incubated AIM-100 / Baricitinib( INCB 028050) management,immunoprecipitation and / or Western blot was used to observe AR phosphorylation. RNA interference targeted silence Tyk2 gene was transfected into LNCa P and LAPC-4 cell lines. Western blot was used to observe the effect on AR phosphorylation. CCK-8 was used to measure cell proliferation. Results EGF can induce AR phosphorylation at Tyr-267 and proliferation of prostate cancer cells( P〈0. 05). AIM-100 inhibited the proliferation of prostate cancer cells( P〈0. 05),and AR Tyr-267 phosphorylation mediated by Ack1 and Tyk2. However,INCB inhibited Tyk2 phosphorylation and AR Tyr-267 phosphorylation as well as the proliferation of prostate cancer cells( P〈0. 05). Conclusions The JAK family member Tyk2 played a critical role in facilitating EGF-induced AR site-specific phosphorylation at Tyr-267 and in promoting prostate cancer cell proliferation.
出处 《基础医学与临床》 CSCD 2016年第11期1499-1504,共6页 Basic and Clinical Medicine
基金 国家自然科学基金(81272842) 国家自然科学基金青年基金(81500157) 北京天坛医院青年基金(20141
关键词 雄激素受体 前列腺癌 磷酸化 Tyk2激酶 EGF androgen receptor prostate cancer phosphorylation Tyk2 kinase EGF
  • 相关文献

参考文献1

二级参考文献11

  • 1Lamont KR,Tindall DJ. Minireview:Alternative activation pathways for the androgen receptor in prostate cancer[J].Molecular Endocrinology,2011.897-907.
  • 2Chen CD,Welsbie DS,Tran C. Molecular determinants of resistance to antiandrogen therapy[J].Nature Medicine,2004.33-39.
  • 3Kraus S,Gioeli D,Vomastek T. Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor[J].CANCER RESEARCH,2006.11047-11054.
  • 4Mahajan NP,Liu Y,Majumder S. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation[J].Proceedings of the National Academy of Sciences(USA),2007.8438-8443.
  • 5Scher HI,Sawyers CL. Biology of progressive,castrationresistant prostate cancer:directed therapies targeting the androgen-receptor signaling axis[J].Journal of Clinical Oncology,2005.8253-8261.
  • 6Guo Z,Dai B,Jiang T. Regulation of androgen receptor activity by tyrosine phosphorylation[J].CANCER CELLS,2006.309-319.
  • 7Liu Y,Majumder S,Mccall W. Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancer[J].CANCER RESEARCH,2005.3404-3409.
  • 8Gregory CW,Fei X,Ponguta LA. Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer[J].Journal of Biological Chemistry,2004.7119-7130.
  • 9Gregory CW,Whang YE,Mccall W. Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growth[J].Clinical Cancer Research,2005.1704-1712.
  • 10Lee LF,Guan J,Qiu Y. Neuropeptide-induced androgen independence in prostate cancer cells:roles of nonreceptor tyrosine kinases Etk/Bmx,Src,and focal adhesion kinase[J].Molecular and Cellular Biology,2001.8385-8397.

共引文献5

同被引文献8

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部